Hematology tests in Dubai & UAE

Compare available Hematology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

114

Listed price range

550.00–7,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hematology test prices

Showing 16–30 of 114 matching tests.

Hematology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-958 BCR‑ABL1 Quantitative (CML MRD1) Monitoring Test This test quantifies the BCR-ABL1 fusion transcript in peripheral blood using real-time quantitative PCR standardized to the International Scale (IS). It is used for monitoring min...	Peripheral whole blood (EDTA tube)	24 hours (verbal); 36 hours (written report)	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcript", "Minimal Residual Disease (MRD)"] Parameters [{"name": "BCR-ABL1 transcript level", "reference_range": "Reported as a percentage on the International Scale (IS)"}] Preparation [] Indications ["Monitoring CML treatment response", "Assessing molecular remission", "Guiding TKI therapy adjustments"] Measurement technique Confirm with laboratory Codes LOINC: 5196-1 ICD-10: C92.10 Clinical summary This test quantifies the BCR-ABL1 fusion transcript in peripheral blood using real-time quantitative PCR standardized to the International Scale (IS). It is used for monitoring minimal residual disease (MRD) in patients with Chronic Myeloid Leukemia (CML).
TEST-1814 Beta Thalassemia Prenatal Screening Test This test evaluates fetal beta globin gene mutations using End-Point PCR.	Amniotic fluid, chorionic villi, umbilical cord blood	3–4 working days from sample receipt	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Fetal beta globin gene mutations"] Parameters [] Preparation ["Consult obstetrician regarding potential medication adjustments (anticoagulants/antiplatelets) before invasive sampling."] Indications ["Prenatal screening for beta thalassemia carriers or affected fetuses"] Measurement technique Confirm with laboratory Codes LOINC: 53926-4 ICD-10: D56.1 Clinical summary This test evaluates fetal beta globin gene mutations using End-Point PCR.
TEST-546 Cardiolipin Antibodies Panel (IgG, IgA & IgM) Test This test quantifies IgG, IgA, and IgM antibodies against cardiolipin, aiding in the diagnosis and risk assessment of antiphospholipid syndrome (APS).	Serum	Same-day reporting (Sample received by 9 AM, Mon–Sat)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Anti-cardiolipin IgG antibodies", "Anti-cardiolipin IgA antibodies", "Anti-cardiolipin IgM antibodies"] Parameters [{"name": "Cardiolipin IgG", "reference_range": "Laboratory-specific reference range"}, {"name": "Cardiolipin IgA", "reference_range": "Laboratory-specific reference range"}, {"name": "Cardiolipin IgM", "reference_range": "Laboratory-specific reference range"}] Preparation ["No special preparation required.", "Patients may eat, drink, and take regular medications."] Indications ["Suspected antiphospholipid syndrome (APS)", "Thromboembolic risk assessment", "Evaluation of recurrent pregnancy loss", "Investigation of thrombocytopenia"] Measurement technique Confirm with laboratory Codes LOINC: 48222-6 ICD-10: D68.61, R79.89 Clinical summary This test quantifies IgG, IgA, and IgM antibodies against cardiolipin, aiding in the diagnosis and risk assessment of antiphospholipid syndrome (APS).
TEST-2132 CD11c Immunophenotyping by Flow Cytometry Test This diagnostic test evaluates the expression level of the CD11c antigen on hematopoietic cells using flow cytometry.	Whole blood (Lavender Top/EDTA, Green Top/Sodium Heparin) or Bone marrow (Green Top/Sodium heparin)	Same-day report (sample by 9 am)	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD11c antigen expression", "Hematopoietic cell populations"] Parameters [{"name": "CD11c Expression", "reference_range": null}] Preparation ["No fasting required", "Provide brief clinical history", "Wear loose clothing for venipuncture if blood sample is taken"] Indications ["Diagnostic workup of mature B-cell neoplasms", "Subclassification of acute myeloid leukemias", "Diagnosis of hairy cell leukemia"] Measurement technique Confirm with laboratory Codes LOINC: 50616-2 ICD-10: C91.0 Clinical summary This diagnostic test evaluates the expression level of the CD11c antigen on hematopoietic cells using flow cytometry.
TEST-1721 Chronic Leukemia Panel Test This test evaluates for chronic leukemia using multiparameter flow cytometry and next-generation sequencing to identify specific immunophenotypes and genetic mutations.	Peripheral blood or bone marrow aspirate	1–2 working days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leukemia-associated immunophenotypes", "BCR-ABL1 genetic aberration", "TP53 genetic aberration", "IGHV genetic aberration"] Parameters [{"name": "Multiparameter flow cytometry (≥10 markers)", "reference_range": null}, {"name": "BCR-ABL1 NGS", "reference_range": null}, {"name": "TP53 NGS", "reference_range": null}, {"name": "IGHV NGS", "reference_range": null}] Preparation ["Provide a doctor’s prescription", "Avoid anticoagulants as advised by the physician"] Indications ["Suspected chronic leukemia", "Confirmed chronic leukemia", "Diagnosis confirmation", "Leukemia subtype classification", "Guidance for targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 96669-7 ICD-10: C95.1 Clinical summary This test evaluates for chronic leukemia using multiparameter flow cytometry and next-generation sequencing to identify specific immunophenotypes and genetic mutations.
TEST-652 Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test This test identifies key genetic mutations in CLL patients to guide treatment decisions and predict disease prognosis.	Whole Blood (4 mL EDTA Lavender Top)	6 Days (Sample arrival Mon 11 AM → Report by Saturday)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TP53 mutation status", "ATM mutation status", "IGHV mutation status", "NOTCH1 mutation status", "SF3B1 mutation status", "BIRC3 mutation status", "MYD88 mutation status"] Parameters [{"name": "TP53", "reference_range": "Mutation detected / Not detected"}, {"name": "ATM", "reference_range": "Mutation detected / Not detected"}, {"name": "IGHV", "reference_range": "Mutated / Unmutated"}, {"name": "NOTCH1", "reference_range": "Mutation detected / Not detected"}, {"name": "SF3B1", "reference_range": "Mutation detected / Not detected"}, {"name": "BIRC3", "reference_range": "Mutation detected / Not detected"}, {"name": "MYD88", "reference_range": "Mutation detected / Not detected"}] Preparation ["No fasting required", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Diagnosis of Chronic Lymphocytic Leukemia (CLL)", "Risk stratification in CLL", "Guidance for targeted therapy selection in CLL"] Measurement technique Confirm with laboratory Codes LOINC: 69548-8 ICD-10: C91.1 Clinical summary This test identifies key genetic mutations in CLL patients to guide treatment decisions and predict disease prognosis.
TEST-2760 Chronic Myeloid Leukemia (CML) NGS Panel Test This test identifies genetic mutations associated with Chronic Myeloid Leukemia (CML), including BCR-ABL1 kinase domain mutations and other resistance variants.	Bone Marrow Aspirate or Peripheral Blood	15 business days (maximum)	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 kinase domain mutations", "Additional gene alterations driving CML progression (e.g., ABL1, ASXL1, RUNX1)"] Parameters [] Preparation ["Fasting for 8 hours prior to collection", "Complete the NGS Test Requisition Form", "Sample collection must occur at an accredited hospital facility"] Indications ["Diagnosis of CML", "Monitoring treatment response", "Detection of resistance mutations", "Guiding tyrosine kinase inhibitor selection"] Measurement technique Confirm with laboratory Codes LOINC: 92928-0 ICD-10: C92.10, C92.11, C92.12 Clinical summary This test identifies genetic mutations associated with Chronic Myeloid Leukemia (CML), including BCR-ABL1 kinase domain mutations and other resistance variants.
TEST-1702 CLL (Chronic Lymphocytic Leukemia) Panel Test This test evaluates chromosomal deletions and duplications in CLL using MLPA technology.	Peripheral Blood or Bone Marrow Aspirate	7–10 business days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal deletions", "Chromosomal duplications", "11q22.3 (ATM)", "13q14.3 (miR-15a/16-1)", "17p13.1 (TP53)"] Parameters [{"name": "11q22.3 (ATM) Deletion/Duplication", "reference_range": null}, {"name": "13q14.3 (miR-15a/16-1) Deletion/Duplication", "reference_range": null}, {"name": "17p13.1 (TP53) Deletion/Duplication", "reference_range": null}] Preparation ["No specific patient preparation required."] Indications ["Diagnosis of CLL", "Risk stratification in CLL", "Guidance for targeted therapy selection", "Minimal residual disease monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 94229-3 ICD-10: C91.1 Clinical summary This test evaluates chromosomal deletions and duplications in CLL using MLPA technology.
TEST-1711 CLL NGS Panel (FISH, Karyotyping, IGHV & TP53 Mutation Analysis) Test This test evaluates key genetic markers in chronic lymphocytic leukemia (CLL) to guide prognosis and treatment.	Peripheral blood or FFPE tissue block	3 weeks	5,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Karyotyping", "FISH (Fluorescence In Situ Hybridization)", "IGHV (Immunoglobulin Heavy Chain Variable Region) mutation status", "TP53 mutation status"] Parameters [] Preparation [] Indications ["Diagnosis of Chronic Lymphocytic Leukemia (CLL)", "Prognosis determination in CLL", "Guiding treatment decisions in CLL"] Measurement technique Confirm with laboratory Codes LOINC: 98196-9 ICD-10: C91.1 Clinical summary This test evaluates key genetic markers in chronic lymphocytic leukemia (CLL) to guide prognosis and treatment.
TEST-1714 CLL Panel (Cytogenetics + FISH) Test This test evaluates for four specific chromosomal abnormalities (del(11q), trisomy 12, del(13q), del(17p)) in chronic lymphocytic leukaemia (CLL) using cytogenetics and FISH.	Bone marrow aspirate or peripheral blood	10 working days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["del(11q)", "trisomy 12", "del(13q)", "del(17p)"] Parameters [] Preparation ["No special fasting required.", "Disclose all blood-thinning medications to the haematology team."] Indications ["Diagnosis of Chronic Lymphocytic Leukaemia (CLL)", "Prognosis determination in CLL", "Guidance for targeted therapy selection in CLL"] Measurement technique Confirm with laboratory Codes LOINC: 97915-5 ICD-10: C91.1 Clinical summary This test evaluates for four specific chromosomal abnormalities (del(11q), trisomy 12, del(13q), del(17p)) in chronic lymphocytic leukaemia (CLL) using cytogenetics and FISH.
TEST-106 Comprehensive Leukemia Panel (SNVs, Small INDELs, CNVs) Test This test evaluates the genomic landscape of leukemia by detecting SNVs, INDELs, and CNVs in over 50 relevant genes using NGS.	Peripheral blood	14–21 business days	4,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Variants (SNVs)", "Small Insertions/Deletions (INDELs)", "Copy Number Variations (CNVs)", "Genomic mutations in >50 leukemia-associated genes"] Parameters [] Preparation ["No fasting required."] Indications ["Diagnosis of acute or chronic leukemia", "Risk stratification in leukemia", "Guidance for targeted therapy selection", "Monitoring minimal residual disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 91847-0 ICD-10: C95.9 Clinical summary This test evaluates the genomic landscape of leukemia by detecting SNVs, INDELs, and CNVs in over 50 relevant genes using NGS.
TEST-953 Deep Vein Thrombosis (DVT) Panel Test This diagnostic test evaluates multiple coagulation factors and markers associated with thrombophilia (inherited or acquired conditions predisposing to blood clots). It assesses th...	Platelet-poor plasma (venous blood)	Next-day (sample received by 3 pm)	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Protein C", "Protein S", "Antithrombin III", "Factor V Leiden", "Prothrombin G20210A mutation", "D‑dimer", "Lupus Anticoagulant", "Coagulation screen"] Parameters [{"name": "Protein C", "reference_range": null}, {"name": "Protein S", "reference_range": null}, {"name": "Antithrombin III", "reference_range": null}, {"name": "Factor V Leiden", "reference_range": null}, {"name": "Prothrombin G20210A mutation", "reference_range": null}, {"name": "D‑dimer", "reference_range": null}, {"name": "Lupus Anticoagulant", "reference_range": null}, {"name": "Complete coagulation screen", "reference_range": null}] Preparation ["Overnight fasting is preferred", "Discontinue heparin 1 day prior (with physician consent)", "Discontinue oral anticoagulants 7 days prior (with physician consent)", "Provide a completed Coagulation Requisition Form (Form 15)"] Indications ["Personal or family history of DVT or PE", "Recurrent unexplained thrombosis", "Thrombosis in unusual sites", "Thrombosis during pregnancy or with estrogen use", "Evaluation of hypercoagulable states"] Measurement technique Confirm with laboratory Codes LOINC: 34534-2 ICD-10: I82.9 Clinical summary This diagnostic test evaluates multiple coagulation factors and markers associated with thrombophilia (inherited or acquired conditions predisposing to blood clots). It assesses the risk of developing deep vein thrombosis.
TEST-1006 Disseminated Intravascular Coagulation (DIC) Profile Test This diagnostic test evaluates the body's coagulation system for signs of disseminated intravascular coagulation (DIC), a life-threatening condition involving abnormal clotting and...	Whole blood (EDTA and Sodium Citrate)	Same-day reporting	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Prothrombin Time (PT)", "Activated Partial Thromboplastin Time (aPTT)", "Fibrinogen", "D-dimer", "Platelet Count"] Parameters [{"name": "Prothrombin Time (PT)", "reference_range": null}, {"name": "Activated Partial Thromboplastin Time (aPTT)", "reference_range": null}, {"name": "Fibrinogen", "reference_range": null}, {"name": "D-dimer", "reference_range": null}, {"name": "Platelet Count", "reference_range": null}] Preparation ["Overnight fasting is preferred", "Bring a completed Coagulation Requisition Form (Form 15)", "Inform doctor about Heparin or oral anticoagulants", "Discontinuation of anticoagulants requires physician approval (Heparin: 1 day, Oral: 7 days)"] Indications ["Suspected sepsis with organ dysfunction", "Major trauma", "Malignancy", "Obstetric complications", "Severe liver disease"] Measurement technique Confirm with laboratory Codes LOINC: 34536-0 ICD-10: D65 Clinical summary This diagnostic test evaluates the body's coagulation system for signs of disseminated intravascular coagulation (DIC), a life-threatening condition involving abnormal clotting and bleeding.
TEST-1070 Erythropoietin (EPO) Test This diagnostic test evaluates serum erythropoietin levels to assess bone marrow function and red blood cell production.	Serum (Peripheral Blood)	Same-day (if collected Mon/Thu by 11 AM)	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Erythropoietin (EPO) levels", "Bone marrow function related to red blood cell production"] Parameters [{"name": "Erythropoietin (EPO)", "reference_range": null}] Preparation ["No fasting or special preparation is required."] Indications ["Diagnosis of anemia", "Diagnosis of polycythemia", "Evaluation of suspected bone marrow disorders", "Assessment of red blood cell production"] Measurement technique Confirm with laboratory Codes LOINC: 20570-8 ICD-10: D64.9 Clinical summary This diagnostic test evaluates serum erythropoietin levels to assess bone marrow function and red blood cell production.
TEST-1607 Extended AML Panel (BCR/ABL, AML/ETO, CBFB, PML/RARA, FLT3, NPM1, CEBPA) Test This test identifies seven critical genetic mutations associated with Acute Myeloid Leukemia (AML) to guide prognosis and treatment decisions.	Bone marrow aspirate or peripheral blood	7–8 working days	3,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR/ABL fusion gene", "AML/ETO fusion gene", "CBFB fusion gene", "PML/RARA fusion gene", "FLT3 mutation", "NPM1 mutation", "CEBPA mutation"] Parameters [{"name": "BCR/ABL", "reference_range": "Negative"}, {"name": "AML/ETO", "reference_range": "Negative"}, {"name": "CBFB", "reference_range": "Negative"}, {"name": "PML/RARA", "reference_range": "Negative"}, {"name": "FLT3", "reference_range": "Negative"}, {"name": "NPM1", "reference_range": "Negative"}, {"name": "CEBPA", "reference_range": "Negative"}] Preparation ["No fasting required", "Inform doctor about all medications, especially blood thinners", "Valid prescription required"] Indications ["Diagnosis of acute myeloid leukemia", "Risk stratification in AML", "Selection of targeted therapy", "Minimal residual disease monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 60560-5 ICD-10: C92.00 Clinical summary This test identifies seven critical genetic mutations associated with Acute Myeloid Leukemia (AML) to guide prognosis and treatment decisions.

Category overview

Hematology: overview

When it comes to your circulatory health, finding precise and timely answers is essential for your peace of mind and ongoing vitality. The Hematology department at DNA Labs UAE uses highly advanced flow cytometry and automated cell counters to thoroughly analyze your blood profile. From routine counts to specialized coagulation and hematology testing in the UAE, these diagnostics provide your doctor with crucial data to manage and monitor blood-related conditions effectively. Trust in one of the most reliable diagnostic labs in Dubai and the UAE to deliver fast, highly accurate results under uncompromising confidentiality standards. Ensure your circulatory wellness today. View our hematology tests, arrange a convenient home collection, or contact our medical experts to schedule your visit.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Hematology tests in Dubai & UAE

Hematology test prices

Hematology: overview

Use the test details as a conversation starter

Related Hematology categories